Hospital ownership of health insurance plans increased from 18.3% in 2018 to 27.2% in 2023, with higher adoption among academic institutions. Effects on care, physician incentives, and costs remain uncertain.

A patient with advanced, treatment-resistant lung cancer experienced complete tumor disappearance after sodium selenite treatment and remained tumor-free for 10 years. The single case cannot establish efficacy, safety, or causality.

Two phase 3 trials found upadacitinib increased scalp, eyebrow, and eyelash regrowth in adolescents and adults with severe alopecia areata. Longer-term safety, durability, and regulatory review remain important considerations.

A multicenter cross-sectional study associated symptomatic uncomplicated diverticular disease with reduced microbial diversity and distinct taxonomic and predicted functional patterns. The findings remain hypothesis-generating and require validation in larger, longitudinal cohorts.

The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.

Dolly Parton reported overlooking personal health concerns while caring for her husband, illustrating how caregiving can delay attention to symptoms. No unifying diagnosis or cause of death was disclosed.